COLLEGIUM PHARMACEUTICAL INC's ticker is and the CUSIP is 19459JAA2. A total of 22 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $45,185 | -99.9% | 46,945,000 | -9.6% | 1.24% | +95.9% |
| Q3 2022 | $45,236,000 | +4.8% | 51,945,000 | 0.0% | 0.64% | -35.5% |
| Q2 2022 | $43,179,000 | +43.5% | 51,945,000 | +62.6% | 0.98% | +40.6% |
| Q1 2022 | $30,087,000 | -2.7% | 31,945,000 | 0.0% | 0.70% | +3.7% |
| Q4 2021 | $30,907,000 | -17.6% | 31,945,000 | -14.2% | 0.68% | -31.9% |
| Q3 2021 | $37,506,000 | -5.8% | 37,245,000 | +5.7% | 0.99% | -10.2% |
| Q2 2021 | $39,802,000 | +19.6% | 35,245,000 | +16.5% | 1.10% | -16.9% |
| Q1 2021 | $33,292,000 | -4.8% | 30,245,000 | -16.0% | 1.33% | -0.9% |
| Q4 2020 | $34,967,000 | +11.7% | 35,995,000 | +10.8% | 1.34% | -20.7% |
| Q3 2020 | $31,313,000 | +444.6% | 32,495,000 | +407.7% | 1.69% | +245.2% |
| Q2 2020 | $5,750,000 | +0.5% | 6,400,000 | -1.5% | 0.49% | -20.1% |
| Q1 2020 | $5,720,000 | – | 6,500,000 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 17,500,000 | $189,560,000 | 2.40% |
| STEELHEAD PARTNERS LLC | 21,000,000 | $22,877,000 | 1.73% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 30,245,000 | $33,292,000 | 1.33% |
| DeepCurrents Investment Group LLC | 8,900,000 | $9,745,000 | 0.34% |
| LINDEN ADVISORS LP | 28,000,000 | $30,455,000 | 0.23% |
| Teton Advisors, Inc. | 500,000 | $542,000 | 0.08% |
| Verition Fund Management LLC | 2,589,000 | $2,823,000 | 0.03% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 190,000 | $206,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 18,000,000 | $19,628,000 | 0.02% |
| GABELLI FUNDS LLC | 3,000,000 | $3,254,000 | 0.02% |